نتائج البحث - "Emilie Scherrer"

1

Cost-Effectiveness of Pembrolizumab for the Adjuvant Treatment of Melanoma Patients with Lymph Node Involvement Who Have Undergone Complete Resection in Argentina

المؤلفون: Victoria Wurcel, Juan Ignacio Altuna, Fernando Carabajal, Gargi Baluni, Raquel Aguiar-Ibáñez, Shrishti Jain, Emilie Scherrer

المصدر: Oncology and Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ffa07f0b556a00966d5479d4441a82Test
https://doi.org/10.1007/s40487-021-00142-8Test

2

An observational study of drug utilization and associated outcomes among adult patients diagnosed with BRAF‐mutant advanced melanoma treated with first‐line anti‐PD‐1 monotherapies or BRAF/MEK inhibitors in a community‐based oncology setting

المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar

المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicine

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test

3

Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanoma

المؤلفون: Steven M. Townson, James Larkin, Emilie Scherrer, Reina Rau, Irene Shui, Maria Lorenzi

المصدر: Future oncology (London, England). 17(20)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c394dfb2529278b1dd27e417d8c10cTest
https://pubmed.ncbi.nlm.nih.gov/33783230Test

4

187 Real-world treatment patterns and clinical predictors of overall survival among anti-PD-1 exposed advanced melanoma patients with documented evidence of disease progression

المؤلفون: Xiaoyun Li, Cathy Anne Pinto, Emilie Scherrer, Mizuho Kalabis, Xinyue Liu

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Medical record, Disease progression, Pembrolizumab, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Stable Disease, Internal medicine, medicine, Nivolumab, business, Social Security Death Index

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a08aa4a18c0690b927dab1976b7af3Test
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575bTest

5

897 Infusion episode-related benefits of pembrolizumab Q6W dosing schedule for patients with melanoma treated in the adjuvant and metastatic settings in the United States (US)

المؤلفون: Anvi Khandelwal, Baanie Sawhney, John Cook, Emilie Scherrer, Shalini Bagga, Raquel Aguiar-Ibáñez, Dmitri Grebennik, Scott Soefje

المصدر: Journal for ImmunoTherapy of Cancer. 9:A941-A941

مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, Melanoma, medicine.medical_treatment, Immunology, Pembrolizumab, medicine.disease, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, Dosing, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7af1f3e3202f213bbd013952090a7809Test
https://doi.org/10.1136/jitc-2021-sitc2021.897Test

6

315 Application of the SITC immunotherapy resistance taskforce definitions of anti-PD-1 resistance to studies evaluating patients with advanced melanoma

المؤلفون: Emilie Scherrer, Eric Druyts, Hussein Tawbi, Irene Shui, Andrew Frederickson

المصدر: Journal for ImmunoTherapy of Cancer. 9:A339-A339

مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunology, Anti pd 1, Immunotherapy, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, business, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c80f3173bbaed1027f6f5053ec9ed425Test
https://doi.org/10.1136/jitc-2021-sitc2021.315Test

7

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song

المصدر: Clinical Drug Investigation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test

8

Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma

المؤلفون: Emilie Scherrer, Wanmei Ou, Eric D. Whitman, Clemens Krepler

المصدر: Future oncology (London, England). 16(20)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecb7e4b6384a254b88279aeefff942cTest
https://pubmed.ncbi.nlm.nih.gov/32410465Test

9

Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review

المؤلفون: Emilie Scherrer, Rachael Miller, Agnes Brandtmüller, Kevin Cadwell, Irene Shui, Sophie Walker

المصدر: Melanoma Management

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5f4697850e66ab1ac2440612678698Test
https://doi.org/10.2217/mmt-2019-0022Test

10

Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers

المؤلفون: Todd A. Lee, Frank Xiaoqing Liu, Alicia C. Shillington, Emilie Scherrer, Vaidehi Dave, Scott J. Diede, Richard W. Joseph, Qing Harshaw, Cynthia Macahilig

المصدر: Journal of medical economics. 23(2)

مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Pembrolizumab, Comorbidity, Severity of Illness Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Melanoma, Aged, 80 and over, 030503 health policy & services, Health Policy, Age Factors, Health Services, Middle Aged, Hospitalization, Nivolumab, 030220 oncology & carcinogenesis, Health Resources, Female, 0305 other medical science, Emergency Service, Hospital, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Advanced melanoma, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Immunotherapy, Emergency department, medicine.disease, Regimen, Socioeconomic Factors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea03f3e3d324c5e59f46dbc80ab03ca2Test
https://pubmed.ncbi.nlm.nih.gov/31750751Test

تنقيح النتائج